Eli Lilly and Evidation expand digital biomarker collaboration to data from smartphones and wearables

Eli Lilly & Co. is expanding its collaboration with Evidation Health into a multiyear project aimed at developing digital biomarkers for disease, derived from smartphones, wearable sensors and even voice data. Lilly’s global scientists and researcher https://www.fiercebiotech.com/medtech/eli-lilly-and-evidation-expand-digital-biomarker-collaboration-to-data-from-smartphones-and